About
About Rewalk Robotics Ltd
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
Visit company website
5 years, 4 months ago
ReWalk Robotics Ltd is currently in a long term downtrend where the price is trading 18.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.1.
ReWalk Robotics Ltd's total revenue rose by 3.1% to $1M since the same quarter in the previous year.
Its net income has increased by 17.6% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 31.8% to $-2M since the same quarter in the previous year.
Based on the above factors, ReWalk Robotics Ltd gets an overall score of 4/5.